Ecuador vs Slovenia: Access to anti-retroviral drugs, male
Ecuador
87.0%
in 2024
Slovenia
87.0%
in 2024
Ecuador rank
27th
Slovenia rank
27th
Access to anti-retroviral drugs, male over time
- Ecuador
- Slovenia
How they compare
Ecuador currently reports 87.0% against 87.0% in Slovenia, a difference of 0.0%.
Across all 25 years both countries report, Slovenia has been ahead every year.
Ecuador ranks 27th and Slovenia ranks 27th of 141 countries.
Slovenia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.2% | 40.8% | 35.6% | Slovenia |
| 2010s | 37.9% | 72.8% | 34.9% | Slovenia |
| 2020s | 79.8% | 85.2% | 5.4% | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Ecuador or Slovenia?
- Ecuador, at 87.0% against 87.0% in Slovenia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Ecuador and Slovenia?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Slovenia?
- 25 years are reported by both, from 2000 to 2024.
- How do Ecuador and Slovenia rank globally for access to anti-retroviral drugs, male?
- Ecuador ranks 27th and Slovenia ranks 27th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.